Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2025-12-26 @ 4:03 AM
Study NCT ID:
NCT04776018
Status:
TERMINATED
Last Update Posted:
2024-10-02
First Post:
2021-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-25
First Submit QC Date:
None
Study First Post Date:
2021-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-30
Results First Submit QC Date:
None
Results First Post Date:
2024-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-09
Last Update Post Date:
2024-10-02
Last Update Post Date Type:
ACTUAL